Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain in patients with COVID-19
IRCT20150725023332N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
bromelain
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150725023332N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150725023332N6.